Fibrinolysis in Liver Diseases Study of 109 Cases by means of the Fibrin Plate Method

Summary

In 109 patients with liver diseases, fibrinolysis was studied by means of the fibrin plate method. A general increase of the fibrinolytic activity was observed in all liver diseases. This finding was particularly evident for the liver cirrhosis and by studying the spontaneous fibrinolysis in plain and precipitated serum and in plain and heated plates, as well as the streptokinase activated fibrinolysis in plain serum and plain plates. Liver malignancies usually showed a normal or subnormal behaviour, with the only exception of the streptokinase activated, precipitated serum in plain plates. Significant differences were found between liver cirrhosis and chronic hepatitis. In heated plates, the differences between liver cirrhosis and other liver diseases (chronic and acute hepatitis, hepatomegaly with liver impairment, malignancies) were not very much pronounced, when streptokinase activated serum was used. For diagnostic purposes, the most suitable tests for studying the fibrinolytic activity by means of the fibrin plate method in liver diseases, are represented by the following combinations: a. plain serum and plain plates; b. streptokinase activated serum and plain plates.

• References

• 1 de Nicola P, Soardi F. Study of fibrinolysis in liver diseases by means of the fibrin plate method (preliminary observations). Proc. VI Congr. Europ. Soc. Hematol., Copenhagen, 1957
• 2 Goodpasture S. Fibrinolysis in chronic hepatic insufficiency. Bull. Johns Hopk. Hosp. 25: 330 1914;
• 3 Ratnoff O. D. Studies on proteolytic enzymes in human plasma. Rate of lysis of plasma clots in normal and diseased individuals, with particular reference to hepatic diseases. Bull. John Hopk. Hosp. 84: 29 1949;
• 4 Stefanini M. Hemorrhagic diathesis of liver dysfunction and obstructive jaundice. Proc. Illrd Congr. Inter. Soc. Hemat., New York, p. 484 (Grune & Stratton, 1951)
• 5 Marrazza P, Serafini U. M, Méne G. La fibrinolisi ematica negli epato-pazienti. Policlinico, Sez. med. 61: 133 1954;
• 6 Buttò M, Masetto L, Zerman A. M. Fibrinolisi, fibrinogenemia, attività protrombinica ed eucolloidità serica in alcuni quadri di epatopatie. Settim. med. 44: 59 1956;
• 7 Beaumont J. L, Beaumont V, Domart A. Recherches sur l’activité fibrino-litique spontanée du plasma dans les cirrhose du foie. Rev. franc, ét. clin. biol. 1: 667 1956;
• 8 Favre-Gilly J, Pollon F. Fibrinolyse et diathése hémorragique et fibrinolytiques. Vigot; Paris: 1952
• 9 Crolle G, Ciancaglini L. Il problema della fibrinolisi. Minerva med. (Torino) 2: 851 1954;
• 10 Kwaan H. C, McFadzean A. J. S, Cook J. Plasma fibrinolytic activity in cirrhosis of the liver. Lancet 1: 132 1956;
• 11 Wille S, Dirnberger P. Über die Verlängerung der Profibrinolysinzeit bei Leberkrankheiten. Klin. Wschr. 33: 1931 1955;
• 12 Whipple G. H, Hurwitz J. P. Fibrinogen of the blood as influenced by the liver necrosis of chloroform. J. exp. Med. 13: 136 1911;
• 13 Nolf P, Adant M. De l’intervention du foie dans les phénomènes de la coagulation du sang. Sang 2: 257 1951;
• 14 Lewis J. H, Ferguson J. H. Activation de la profibrinolyse. Rev. Hémat. 7: 6 1952;
• 15 Astrup T, Miillertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Bioch. Biophys. 40: 346 1952;
• 16 Miillertz S. Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochem. J. 61: 424 1955;